Famed healthcare company GoodRx is a well-known resource to patients nationwide, especially when it comes to finding information about and discounts on medications.
The company’s latest venture into healthcare is through its launch of GoodRx Gold, a membership based healthcare savings program. Earlier this week, the company outlined the details of how it plans to enhance the service. As a means to augment its existing prescription medication savings offerings, the new Gold plan will provide members with the ability to: “See a doctor or healthcare provider online for as little as $10 per visit; Get treatments and prescriptions for conditions ranging from acne to high cholesterol; Use [the] GoodRx app or discount card to save big at the pharmacy counter; Get prescriptions delivered to [the] door without leaving home.”
Indeed, the company is aiming to create an end-to-end healthcare service platform, starting with connecting patients to clinical providers, to ultimately getting discounted prescription medications delivered to the patient’s door.
With regards to affordability and the logistics of signing up for the plan, the company states that “Online consultations are available now on individual GoodRx Gold membership plans, and will be available on family plans starting in 2021. A subscription to GoodRx Gold is just $5.99 a month for an individual and $9.99 a month for a family of up to six.”
However, GoodRx’s path to market success is lined with heavy competition. Due to the Covid-19/Coronavirus pandemic and other market factors, telehealth services have grown exponentially this year. This was partly augmented by the U.S. government’s emergency declaration earlier this year and actions to expand Medicare coverage for telehealth services.
The private sector has truly embraced this growth. Large telehealth service companies such as Teladoc Health and Amwell have seen incredible growth in their market share and client base, especially as they were able to provide a critical venue for healthcare services during the height of the pandemic and when stay-at-home restrictions were in full effect.
Regardless of the specific company, the expansion of this field and its disruption against the traditional “in-person healthcare office visit” will only likely continue to grow, as telehealth platforms may potentially be able to increasingly provide more convenient and affordable value to patients. Nonetheless, these companies still have many intricacies to figure out, such as privacy protections, the ever-growing conundrum of how to store endless streams of patient-data digitally, and how liability will work through these platforms—just a few among the many issues that still need to be addressed. Indeed, albeit the growth and increased interest, regulators, providers, and stakeholders must ultimately ensure that patient safety, privacy, and autonomy remain a priority.
The content of this article is not implied to be and should not be relied on or substituted for professional medical advice, diagnosis, or treatment by any means, and is not written or intended as such. This content is for information and news purposes only. Consult with a trained medical professional for medical advice.